Former ghostwriter, Alastair Matheson, talks to BMJ about how the pharmaceutical industry found a loophole to continue composing articles in medical journals without admitting who has actually written the piece. “Numerous articles are produced for journal publication every year, scientific platforms and publications plans are developed, academics are recruited to participate as authors, trade writers draft manuscripts, and substantial payments pass from corporations to agencies, but little of this activity is in the public domain.”
Support MIA
MIA relies on the support of its readers to exist. Please consider a donation to help us provide news, essays, podcasts and continuing education courses that explore alternatives to the current paradigm of psychiatric care. Your tax-deductible donation will help build a community devoted to creating such change.